eFFECTOR Therapeutics (EFTR) Earnings Date, Estimates & Call Transcripts $0.03 -0.01 (-28.33%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEFTR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EFTR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. eFFECTOR Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($2.06)($2.06)($2.06)Q2 20241($1.53)($1.53)($1.53)Q3 20241($1.22)($1.22)($1.22)Q4 20241($1.02)($1.02)($1.02)FY 20244($5.83)($5.83)($5.83) Get eFFECTOR Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for EFTR and its competitors with MarketBeat's FREE daily newsletter. eFFECTOR Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks5/9/2024Q1 2024($2.17)($2.16)+$0.01($2.16)--3/25/2024Q4 2023($2.73)($3.42)($0.69)($3.42)--11/13/2023Q3 2023($3.25)($3.25)-($0.13)--8/8/2023Q2 2023($4.75)($4.25)+$0.50($0.17)--5/9/2023Q1 2023($5.50)($6.00)($0.50)($0.24)--3/8/2023Q4 2022($4.50)($5.50)($1.00)($0.22)-$0.67 million Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022($6.75)($5.75)+$1.00($0.23)-$0.87 million8/9/2022Q2 2022($4.50)($4.25)+$0.25($0.17)-$2.01 million5/10/2022Q1 2022($8.00)$1.75+$9.75$0.07--3/16/2022Q4 2021($6.25)$11.00+$17.25$0.44-$0.31 million11/8/2021Q3 2021($6.50)$10.50+$17.00$0.42-$0.43 million eFFECTOR Therapeutics Earnings - Frequently Asked Questions How much revenue does eFFECTOR Therapeutics generate each year? eFFECTOR Therapeutics (NASDAQ:EFTR) has a recorded annual revenue of $3.55 million. How much profit does eFFECTOR Therapeutics generate each year? eFFECTOR Therapeutics (NASDAQ:EFTR) has a recorded net income of -$35.81 million. EFTR has generated -$13.08 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: APVO Earnings CMRA Earnings TCON Earnings BLPH Earnings SMFL Earnings PRFX Earnings NEXI Earnings ADTX Earnings CNSP Earnings NAVB Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:EFTR) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
